Numb. | TREATMENT //carcinogen (if not AOM) and /mice (if not rats) | Category | Author, year (click name for abstract) | Potency on tumor incidence | Tumor percent inhibition | Cancer percent inhibition | Potency on tumor multiplic. | Protocol | blinded scoring | Ro- dents | carcinogen N x dose | weeks | Tum. in Contrl | No. of Contrl Rats | Tum. in treatd | No. of Treated Rats | Potency on tumor incidence | Carcin. in ctrl | Contrl rats | Carcin. in treatd | Treated rats | Cancer percent inhibition | Multiplic. in contrl | Multiplic. in treatd | Potency on tumor multiplic. | Agent (3 lett.) or comment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T257 | etodolac 10 mg/kg //dss /mice | NSAI+ | Mukawa 08 | 1.21 | 18 | 2.3 | post | M | dss 2x7d 3% | ? | 14 | 14 | 14 | 17 | 1.21 | 3.00 | 1.29 | 2.3 | eto |
To download data in Excel: select data (Ctrl-A), copy/paste (Ctrl-C) in an empty Excel page (Ctrl-V)